Science
Personalized Immunotherapy Response Studied in Body-on-a-Chip Cancer Models – Newswise
Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform…
Newswise — WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest…
Continue Reading